Publication | Closed Access

Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL

Hematological MalignancyLymphoid NeoplasiaMedicineHematologyImmunologyPathologyModified CyclophosphamideB Cell LymphomaAdult T-cell Leukemia-lymphomaImmunotherapyOncologyBurkitt Lymphoma